Jefferies Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Jefferies Financial Group’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.84M	Hold	6,200	–	–	0.01%	671
2025 Q4	$1.88M	Buy	+6,200	New	+$2.03M	0.01%	839
2025 Q3	–	Sell	-2,900	Closed	-$702K	–	1740
2025 Q2	$702K	Hold	2,900	–	–	0.01%	818
2025 Q1	$789K	Buy	2,900 +900	+45%	+$210K	0.01%	896
2024 Q4	$369K	Buy	+2,000	New	+$409K	﹤0.01%	1197
2024 Q2	–	Sell	-8,043	Closed	-$1.26M	–	1945
2024 Q1	$1.26M	Sell	8,043 -37,957	-83%	-$6.11M	0.01%	739
2023 Q4	$8.3M	Hold	46,000	–	–	0.05%	268
2023 Q3	$8.27M	Buy	+46,000	New	+$9.1M	0.07%	208

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jefferies Financial Group's ONC Position: Q1 2026 in Review

Jefferies Financial Group held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 6,200 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #671.

Jefferies Financial Group first reported a position in ONC in Q3 2023 and has held it in 8 quarters since. The position peaked at $8.3M in Q4 2023. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Jefferies Financial Group held 6,200 shares of BeOne Medicines Ltd worth $1.84M as of Q1 2026.
Jefferies Financial Group left its BeOne Medicines Ltd share count unchanged in Q1 2026.
BeOne Medicines Ltd made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #671 holding.
Jefferies Financial Group first reported a position in BeOne Medicines Ltd in Q3 2023 and has held it in 8 quarters since.
Jefferies Financial Group's BeOne Medicines Ltd position peaked at $8.3M in Q4 2023.
281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.